JP2021182946A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021182946A5 JP2021182946A5 JP2021144677A JP2021144677A JP2021182946A5 JP 2021182946 A5 JP2021182946 A5 JP 2021182946A5 JP 2021144677 A JP2021144677 A JP 2021144677A JP 2021144677 A JP2021144677 A JP 2021144677A JP 2021182946 A5 JP2021182946 A5 JP 2021182946A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- compound according
- composition
- isobutyryl
- dmf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022005584A JP7308309B2 (ja) | 2014-05-01 | 2022-01-18 | オリゴヌクレオチド組成物及びその作製方法 |
| JP2023060170A JP2023073510A (ja) | 2014-05-01 | 2023-04-03 | オリゴヌクレオチド組成物及びその作製方法 |
| JP2025188613A JP2026016798A (ja) | 2014-05-01 | 2025-11-07 | オリゴヌクレオチド組成物及びその作製方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461987396P | 2014-05-01 | 2014-05-01 | |
| US61/987,396 | 2014-05-01 | ||
| US201562151909P | 2015-04-23 | 2015-04-23 | |
| US62/151,909 | 2015-04-23 | ||
| JP2019234301A JP2020050670A (ja) | 2014-05-01 | 2019-12-25 | オリゴヌクレオチド組成物及びその作製方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019234301A Division JP2020050670A (ja) | 2014-05-01 | 2019-12-25 | オリゴヌクレオチド組成物及びその作製方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022005584A Division JP7308309B2 (ja) | 2014-05-01 | 2022-01-18 | オリゴヌクレオチド組成物及びその作製方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021182946A JP2021182946A (ja) | 2021-12-02 |
| JP2021182946A5 true JP2021182946A5 (enExample) | 2022-01-26 |
| JP7736489B2 JP7736489B2 (ja) | 2025-09-09 |
Family
ID=54359301
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016564990A Active JP7040892B2 (ja) | 2014-05-01 | 2015-04-29 | オリゴヌクレオチド組成物及びその作製方法 |
| JP2018088277A Pending JP2018131453A (ja) | 2014-05-01 | 2018-05-01 | オリゴヌクレオチド組成物及びその作製方法 |
| JP2019234301A Withdrawn JP2020050670A (ja) | 2014-05-01 | 2019-12-25 | オリゴヌクレオチド組成物及びその作製方法 |
| JP2021144677A Active JP7736489B2 (ja) | 2014-05-01 | 2021-09-06 | オリゴヌクレオチド組成物及びその作製方法 |
| JP2022005584A Active JP7308309B2 (ja) | 2014-05-01 | 2022-01-18 | オリゴヌクレオチド組成物及びその作製方法 |
| JP2023060170A Withdrawn JP2023073510A (ja) | 2014-05-01 | 2023-04-03 | オリゴヌクレオチド組成物及びその作製方法 |
| JP2025188613A Pending JP2026016798A (ja) | 2014-05-01 | 2025-11-07 | オリゴヌクレオチド組成物及びその作製方法 |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016564990A Active JP7040892B2 (ja) | 2014-05-01 | 2015-04-29 | オリゴヌクレオチド組成物及びその作製方法 |
| JP2018088277A Pending JP2018131453A (ja) | 2014-05-01 | 2018-05-01 | オリゴヌクレオチド組成物及びその作製方法 |
| JP2019234301A Withdrawn JP2020050670A (ja) | 2014-05-01 | 2019-12-25 | オリゴヌクレオチド組成物及びその作製方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022005584A Active JP7308309B2 (ja) | 2014-05-01 | 2022-01-18 | オリゴヌクレオチド組成物及びその作製方法 |
| JP2023060170A Withdrawn JP2023073510A (ja) | 2014-05-01 | 2023-04-03 | オリゴヌクレオチド組成物及びその作製方法 |
| JP2025188613A Pending JP2026016798A (ja) | 2014-05-01 | 2025-11-07 | オリゴヌクレオチド組成物及びその作製方法 |
Country Status (33)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ME02933B (me) | 2004-07-02 | 2018-04-20 | Geron Corp | Sinteza zaštićenih 3'-amino nukleozionih monomera |
| JOP20200257A1 (ar) * | 2014-05-01 | 2017-06-16 | Geron Corp | تركيبات أوليجو نوكليوتيد وطرق لتحضيرها |
| KR102401252B1 (ko) * | 2015-04-23 | 2022-05-24 | 제론 코포레이션 | 다가 양이온 염 조성물을 사용한 폴리뉴클레오티드 제조의 방법 |
| JP7199410B2 (ja) * | 2017-07-10 | 2023-01-05 | ジェロン・コーポレーション | 改善されたイメテルスタットの調製方法 |
| EP4523681A1 (en) | 2019-10-28 | 2025-03-19 | Geron Corporation | Amorphous solid succinylated 3-(fatty acid amido)-2-hydroxy-1-(protected hydroxy)-propane salts and methods of making the same |
| CA3155391A1 (en) | 2019-10-28 | 2021-05-06 | Geron Corporation | Crystalline solids of 3-palmitoyl-amido-1,2-propanediol and 3-palmitoyl-amido-2-hydroxy-1-dimethoxytriphenylmethylether-propane and methods of making and using the same |
| CN115315430A (zh) * | 2020-01-08 | 2022-11-08 | 日东电工株式会社 | 使用了链段型亚磷酰胺化合物的核酸合成法 |
| US12565641B2 (en) | 2021-10-15 | 2026-03-03 | Codexis, Inc. | Engineered terminal deoxynucleotidyl transferase variants |
| KR20250008345A (ko) | 2023-07-07 | 2025-01-14 | 주식회사 엘지에너지솔루션 | 체결기구 및 체결기구를 포함하는 전지팩 |
Family Cites Families (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4046720A (en) | 1974-01-17 | 1977-09-06 | California Institute Of Technology | Crosslinked, porous, polyacrylate beads |
| US4394448A (en) | 1978-02-24 | 1983-07-19 | Szoka Jr Francis C | Method of inserting DNA into living cells |
| US4678814A (en) | 1981-03-30 | 1987-07-07 | California Institute Of Technology | Polyacrolein microspheres |
| US4413070A (en) | 1981-03-30 | 1983-11-01 | California Institute Of Technology | Polyacrolein microspheres |
| US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US6448392B1 (en) | 1985-03-06 | 2002-09-10 | Chimerix, Inc. | Lipid derivatives of antiviral nucleosides: liposomal incorporation and method of use |
| US5185444A (en) | 1985-03-15 | 1993-02-09 | Anti-Gene Deveopment Group | Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages |
| US4757141A (en) | 1985-08-26 | 1988-07-12 | Applied Biosystems, Incorporated | Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof |
| US4659774A (en) | 1985-11-01 | 1987-04-21 | American Hoechst Corporation | Support for solid-phase oligonucleotide synthesis |
| US4904582A (en) | 1987-06-11 | 1990-02-27 | Synthetic Genetics | Novel amphiphilic nucleic acid conjugates |
| DE69008521T2 (de) | 1989-03-07 | 1994-10-20 | Genentech Inc | Kovalente konjugate von lipiden und oligonukleotiden. |
| US4958013A (en) | 1989-06-06 | 1990-09-18 | Northwestern University | Cholesteryl modified oligonucleotides |
| US5411947A (en) | 1989-06-28 | 1995-05-02 | Vestar, Inc. | Method of converting a drug to an orally available form by covalently bonding a lipid to the drug |
| US6114513A (en) | 1990-01-11 | 2000-09-05 | Isis Pharmaceuticals, Inc. | Thiol-derivatized oligonucleotides |
| US6395492B1 (en) | 1990-01-11 | 2002-05-28 | Isis Pharmaceuticals, Inc. | Derivatized oligonucleotides having improved uptake and other properties |
| US6153737A (en) | 1990-01-11 | 2000-11-28 | Isis Pharmaceuticals, Inc. | Derivatized oligonucleotides having improved uptake and other properties |
| EP0537299A1 (en) | 1990-03-29 | 1993-04-21 | Gilead Sciences, Inc. | Oligonucleotide-transport agent disulfide conjugates |
| US5420330A (en) | 1990-09-07 | 1995-05-30 | Pharmacia P-L Biochemicals Inc. | Lipo-phosphoramidites |
| US5419966A (en) | 1991-06-10 | 1995-05-30 | Microprobe Corporation | Solid support for synthesis of 3'-tailed oligonucleotides |
| US5633360A (en) | 1992-04-14 | 1997-05-27 | Gilead Sciences, Inc. | Oligonucleotide analogs capable of passive cell membrane permeation |
| US5629154A (en) | 1993-11-12 | 1997-05-13 | Geron Corporation | Telomerase activity assays |
| US5489508A (en) | 1992-05-13 | 1996-02-06 | University Of Texas System Board Of Regents | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| US5837453A (en) | 1992-05-13 | 1998-11-17 | Geron Corporation | Telomerase activity assays |
| US6235886B1 (en) | 1993-09-03 | 2001-05-22 | Isis Pharmaceuticals, Inc. | Methods of synthesis and use |
| IL107150A0 (en) | 1992-09-29 | 1993-12-28 | Isis Pharmaceuticals Inc | Oligonucleotides having a conserved g4 core sequence |
| US7067497B2 (en) | 1992-09-29 | 2006-06-27 | Isis Pharmaceuticals, Inc. | Modulation of telomere length by oligonucleotides having a G-core sequence |
| US6087491A (en) | 1993-01-08 | 2000-07-11 | Hybridon, Inc. | Extremely high purity oligonucleotides and methods of synthesizing them using dimer blocks |
| US5476925A (en) | 1993-02-01 | 1995-12-19 | Northwestern University | Oligodeoxyribonucleotides including 3'-aminonucleoside-phosphoramidate linkages and terminal 3'-amino groups |
| US6350853B1 (en) | 1993-04-26 | 2002-02-26 | Peter E. Nielsen | Conjugated peptide nucleic acids having enhanced cellular uptake |
| DE4331670A1 (de) | 1993-09-17 | 1995-03-23 | Hoechst Ag | Neue Antisense-Oligonucleotide gegen HSV-1 sowie deren Herstellung |
| DE69434569T2 (de) | 1993-10-18 | 2006-08-24 | The Walter And Eliza Hall Institute Of Medical Research, Parkville | Verfahren zur erhöhung der überlebensrate von neuronen und dafür verwendbare mittel |
| US5863726A (en) | 1993-11-12 | 1999-01-26 | Geron Corporation | Telomerase activity assays |
| US5599922A (en) | 1994-03-18 | 1997-02-04 | Lynx Therapeutics, Inc. | Oligonucleotide N3'-P5' phosphoramidates: hybridization and nuclease resistance properties |
| US5726297A (en) | 1994-03-18 | 1998-03-10 | Lynx Therapeutics, Inc. | Oligodeoxyribonucleotide N3' P5' phosphoramidates |
| JP3482209B2 (ja) | 1994-03-18 | 2003-12-22 | ジェロン・コーポレーション | オリゴヌクレオチドｎ３’→ｐ５’ホスホルアミデート：合成および化合物；ハイブリダイゼーションおよびヌクレアーゼ耐性特性 |
| GB9413035D0 (en) | 1994-06-29 | 1994-08-17 | Scras | Antisense oligonucleeotides |
| US5583016A (en) | 1994-07-07 | 1996-12-10 | Geron Corporation | Mammalian telomerase |
| CZ3497A3 (en) | 1994-07-07 | 1997-10-15 | Geron Corp | Rna component of mammal telomerase, oligonucleotide, recombinant expression plasmid containing the oligonucleotide, process for preparing eukaryotic host cell, process for preparing a recombinant telomerase enzyme |
| US5958680A (en) | 1994-07-07 | 1999-09-28 | Geron Corporation | Mammalian telomerase |
| AU4101396A (en) | 1994-11-07 | 1996-05-31 | Hybridon, Inc. | Synthesis of 35s-labeled oligonucleotides with 3h-1,2-benzodithiol-3-1,1-dioxide |
| US5760062A (en) | 1995-04-18 | 1998-06-02 | Geron Corporation | Telomerase inhibitors |
| US5656638A (en) | 1995-04-18 | 1997-08-12 | Geron Corporation | Telomerase inhibitors |
| US5863936A (en) | 1995-04-18 | 1999-01-26 | Geron Corporation | Telomerase inhibitors |
| US5840490A (en) | 1995-06-07 | 1998-11-24 | Mcmaster University | Telomerase activity associated with hematological and colorectal malignancies |
| US5770613A (en) | 1995-09-29 | 1998-06-23 | Geron Corporation | Telomerase inhibitors |
| US5767278A (en) | 1995-10-06 | 1998-06-16 | Geron Corporation | Telomerase inhibitors |
| US5684143A (en) | 1996-02-21 | 1997-11-04 | Lynx Therapeutics, Inc. | Oligo-2'-fluoronucleotide N3'->P5' phosphoramidates |
| US5859233A (en) | 1996-02-21 | 1999-01-12 | Lynx Therapeutics, Inc. | Synthons for synthesis of oligonucleotide N3-P5 phosphoramidates |
| GB9606158D0 (en) | 1996-03-23 | 1996-05-29 | Ciba Geigy Ag | Chemical compounds |
| US6015710A (en) | 1996-04-09 | 2000-01-18 | The University Of Texas System | Modulation of mammalian telomerase by peptide nucleic acids |
| AU2445997A (en) | 1996-04-10 | 1997-10-29 | Lynx Therapeutics, Inc. | Telomerase inhibitors |
| US6111085A (en) | 1996-09-13 | 2000-08-29 | Isis Pharmaceuticals, Inc. | Carbamate-derivatized nucleosides and oligonucleosides |
| US6261836B1 (en) | 1996-10-01 | 2001-07-17 | Geron Corporation | Telomerase |
| US6444650B1 (en) | 1996-10-01 | 2002-09-03 | Geron Corporation | Antisense compositions for detecting and inhibiting telomerase reverse transcriptase |
| US6001991A (en) | 1996-10-04 | 1999-12-14 | Isis Pharmaceuticals Inc. | Antisense oligonucleotide modulation of MDR P-glycoprotein gene expression |
| US5846723A (en) | 1996-12-20 | 1998-12-08 | Geron Corporation | Methods for detecting the RNA component of telomerase |
| JP2001507229A (ja) | 1996-12-20 | 2001-06-05 | ジェロン コーポレイション | テロメラーゼのｒｎａ成分を検出および阻害するための方法 |
| US5877309A (en) | 1997-08-13 | 1999-03-02 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotides against JNK |
| US5998604A (en) | 1997-09-15 | 1999-12-07 | The Perkin-Elmer Corporation | Polynucleotide purification method |
| JP3722630B2 (ja) | 1998-10-28 | 2005-11-30 | パイオニア株式会社 | 記録再生装置 |
| US6656730B1 (en) | 1999-06-15 | 2003-12-02 | Isis Pharmaceuticals, Inc. | Oligonucleotides conjugated to protein-binding drugs |
| DK1210357T3 (da) | 1999-09-10 | 2008-07-21 | Geron Corp | Oligonukleotid-N3' -P5' -thiophosphoramidater: syntese og anvendelse deraf |
| GB9927674D0 (en) * | 1999-11-23 | 2000-01-19 | Aegis Eng Ltd | Protective material |
| US6331399B1 (en) | 2000-05-16 | 2001-12-18 | Isis Pharmaceuticals, Inc. | Antisense inhibition of tert expression |
| US7563618B2 (en) | 2001-03-23 | 2009-07-21 | Geron Corporation | Oligonucleotide conjugates |
| WO2002077184A2 (en) * | 2001-03-23 | 2002-10-03 | Geron Corporation | Oligonucleotide conjugates |
| KR101298493B1 (ko) | 2003-09-09 | 2013-08-21 | 제론 코포레이션 | 텔로머라제 억제를 위한 변형 올리고뉴클레오티드 |
| US20120329858A1 (en) * | 2010-08-04 | 2012-12-27 | Geron Corporation | Modified oligonucleotides for telomerase inhibition |
| ME02933B (me) | 2004-07-02 | 2018-04-20 | Geron Corp | Sinteza zaštićenih 3'-amino nukleozionih monomera |
| US7427675B2 (en) * | 2004-08-23 | 2008-09-23 | Isis Pharmaceuticals, Inc. | Compounds and methods for the characterization of oligonucleotides |
| CA2584984A1 (en) * | 2004-10-18 | 2006-04-27 | Codon Devices, Inc. | Methods for assembly of high fidelity synthetic polynucleotides |
| US7998938B2 (en) | 2005-04-15 | 2011-08-16 | Geron Corporation | Cancer treatment by combined inhibition of proteasome and telomerase activities |
| US8153604B2 (en) * | 2006-04-24 | 2012-04-10 | Geron Corporation | CNS-tumor treatment method and composition |
| EP4474480A2 (en) | 2006-10-30 | 2024-12-11 | Geron Corporation | Combined telomerase inhibitor and gemcitabine for the treatment of cancer |
| US8785409B2 (en) * | 2007-01-30 | 2014-07-22 | Geron Corporation | Compounds having anti-adhesive effects on cancer cells |
| US9106103B2 (en) | 2011-09-23 | 2015-08-11 | Eaton Corporation | Unintteruptible power supply systems and methods employing on-demand energy storage |
| US9006630B2 (en) | 2012-01-13 | 2015-04-14 | Altasens, Inc. | Quality of optically black reference pixels in CMOS iSoCs |
| US20150342982A1 (en) | 2012-12-07 | 2015-12-03 | Geron Corporation | Use of Telomerase Inhibitors for the Treatment of Myeloproliferative Disorders and Myeloproliferative Neoplasms |
| US9375485B2 (en) | 2012-12-07 | 2016-06-28 | Geron Corporation | Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms |
| JOP20200257A1 (ar) | 2014-05-01 | 2017-06-16 | Geron Corp | تركيبات أوليجو نوكليوتيد وطرق لتحضيرها |
-
2014
- 2014-05-01 JO JOP/2020/0257A patent/JOP20200257A1/ar unknown
-
2015
- 2015-04-29 CN CN201580022353.4A patent/CN106459134B/zh active Active
- 2015-04-29 CN CN202311295220.7A patent/CN117357548A/zh active Pending
- 2015-04-29 SI SI201531963T patent/SI3137479T1/sl unknown
- 2015-04-29 KR KR1020167029996A patent/KR102316282B1/ko active Active
- 2015-04-29 MX MX2016014178A patent/MX382233B/es unknown
- 2015-04-29 HU HUE15785822A patent/HUE064289T2/hu unknown
- 2015-04-29 JP JP2016564990A patent/JP7040892B2/ja active Active
- 2015-04-29 UA UAA201610381A patent/UA126108C2/uk unknown
- 2015-04-29 MY MYPI2016703971A patent/MY178617A/en unknown
- 2015-04-29 FI FIEP15785822.6T patent/FI3137479T3/fi active
- 2015-04-29 SG SG10201911086XA patent/SG10201911086XA/en unknown
- 2015-04-29 BR BR112016025196-2A patent/BR112016025196B1/pt active IP Right Grant
- 2015-04-29 ES ES15785822T patent/ES2963740T3/es active Active
- 2015-04-29 RS RS20231110A patent/RS64860B1/sr unknown
- 2015-04-29 LT LTEPPCT/US2015/028327T patent/LT3137479T/lt unknown
- 2015-04-29 CN CN202010050944.5A patent/CN111228288B/zh active Active
- 2015-04-29 TW TW104113709A patent/TWI709406B/zh active
- 2015-04-29 JO JOP/2015/0089A patent/JO3767B1/ar active
- 2015-04-29 PE PE2016002150A patent/PE20170147A1/es unknown
- 2015-04-29 PL PL15785822.6T patent/PL3137479T3/pl unknown
- 2015-04-29 KR KR1020237018801A patent/KR20230088509A/ko not_active Ceased
- 2015-04-29 KR KR1020247031813A patent/KR20240144488A/ko active Pending
- 2015-04-29 SM SM20230405T patent/SMT202300405T1/it unknown
- 2015-04-29 DK DK15785822.6T patent/DK3137479T5/da active
- 2015-04-29 KR KR1020217033531A patent/KR102707216B1/ko active Active
- 2015-04-29 MY MYPI2020002421A patent/MY196927A/en unknown
- 2015-04-29 EP EP23193452.2A patent/EP4286519A3/en active Pending
- 2015-04-29 HR HRP20231505TT patent/HRP20231505T1/hr unknown
- 2015-04-29 WO PCT/US2015/028327 patent/WO2015168310A1/en not_active Ceased
- 2015-04-29 EP EP15785822.6A patent/EP3137479B1/en active Active
- 2015-04-29 EA EA201691786A patent/EA034882B9/ru unknown
- 2015-04-29 AU AU2015253158A patent/AU2015253158B2/en active Active
- 2015-04-29 TW TW108147051A patent/TWI712413B/zh active
- 2015-04-29 US US14/699,902 patent/US9796747B2/en active Active
- 2015-04-29 PT PT157858226T patent/PT3137479T/pt unknown
- 2015-04-29 AP AP2016009489A patent/AP2016009489A0/en unknown
- 2015-04-29 MA MA63525A patent/MA63525B1/fr unknown
- 2015-04-29 SG SG11201608226YA patent/SG11201608226YA/en unknown
-
2016
- 2016-09-23 ZA ZA2016/06624A patent/ZA201606624B/en unknown
- 2016-09-26 IL IL248044A patent/IL248044B/en active IP Right Grant
- 2016-10-19 PH PH12016502080A patent/PH12016502080A1/en unknown
- 2016-10-28 MX MX2021004932A patent/MX2021004932A/es unknown
- 2016-10-28 CL CL2016002749A patent/CL2016002749A1/es unknown
-
2017
- 2017-09-14 US US15/705,019 patent/US10392418B2/en active Active
- 2017-09-14 US US15/705,021 patent/US11299511B2/en active Active
-
2018
- 2018-05-01 JP JP2018088277A patent/JP2018131453A/ja active Pending
- 2018-05-04 CL CL2018001212A patent/CL2018001212A1/es unknown
- 2018-05-04 CL CL2018001213A patent/CL2018001213A1/es unknown
-
2019
- 2019-08-07 IL IL268570A patent/IL268570B/en unknown
- 2019-12-25 JP JP2019234301A patent/JP2020050670A/ja not_active Withdrawn
-
2020
- 2020-03-06 AU AU2020201707A patent/AU2020201707B2/en active Active
- 2020-09-22 ZA ZA2020/05857A patent/ZA202005857B/en unknown
-
2021
- 2021-09-06 JP JP2021144677A patent/JP7736489B2/ja active Active
-
2022
- 2022-01-18 JP JP2022005584A patent/JP7308309B2/ja active Active
- 2022-01-26 CL CL2022000202A patent/CL2022000202A1/es unknown
- 2022-03-16 US US17/696,300 patent/US11739114B2/en active Active
- 2022-05-16 AU AU2022203273A patent/AU2022203273A1/en not_active Abandoned
-
2023
- 2023-04-03 JP JP2023060170A patent/JP2023073510A/ja not_active Withdrawn
- 2023-06-07 US US18/330,935 patent/US20240150391A1/en not_active Abandoned
-
2024
- 2024-01-05 US US18/405,775 patent/US20250011359A1/en not_active Abandoned
-
2025
- 2025-11-07 JP JP2025188613A patent/JP2026016798A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021182946A5 (enExample) | ||
| CA2623522C (en) | Modified 4'-nucleosides as antiviral agents | |
| US20030028013A1 (en) | Novel nucleosides having bicyclic sugar moiety | |
| US6403566B1 (en) | Nucleosides having bicyclic sugar moiety | |
| Watanabe et al. | Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides | |
| US8470987B2 (en) | Protective group for synthesis of RNA and derivative | |
| JP2017514479A5 (enExample) | ||
| KR100279953B1 (ko) | 항-b형 간염 바이러스제 및 항-사람 면역결핍 바이러스제로서의 l-2',3'-디데옥시 누클레오시드 유사체 | |
| CA2584367A1 (en) | Fluorinated pyrrolo[2,3-d]pyrimidine nucleosides for the treatment of rna-dependent rna viral infection | |
| EP1572705A2 (en) | Sugar modified nucleosides as viral replication inhibitors | |
| JP2018538302A5 (enExample) | ||
| JP6671355B2 (ja) | 呼吸器多核体ウイルスのｒｎａ複製の阻害剤としての４’‐ビニル置換ヌクレオシド誘導体 | |
| EP0479640A2 (en) | Novel phosphonate derivatives of certain nucleosides | |
| FI94763C (fi) | Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi | |
| WO2024077111A3 (en) | Compositions, methods, and systems for detecting nucleotides | |
| AU636678B2 (en) | Nucleoside derivatives | |
| US10087209B2 (en) | Antiviral compounds, a process for their preparation, and their use for treating viral infections | |
| JP2020537652A5 (enExample) | ||
| Herdewijn et al. | Nucleotides. Part. XXXII. Synthesis of 2′–5′ Connected oligonucleotides. Prodrugs for antiviral and antitumoral nucleosides | |
| JP2001335592A (ja) | ４’−ｃ−エチニルプリンヌクレオシド化合物 | |
| JP2001517659A5 (enExample) | ||
| JP2001335593A (ja) | ４’−ｃ−エチニルピリミジンヌクレオシド化合物 | |
| Chevrier et al. | Synthesis of 5, 5-difluoro-5-phosphono-pent-2-en-1-yl nucleosides as potential antiviral agents | |
| Lashley | Investigations into 5ꞌ-Extended 3-Deazaaristeromycin Derivatives | |
| CZ20004181A3 (cs) | Sloučenina zahrnující nukleosid s 2',4'-můstkem a oligonukleotid od ní odvozený |